DISCOVERYBIOMED, INC.

Basic Information

400 Riverhills Business Park
BIRMINGHAM, AL, 35242-5038

http://www.discoverybiomed.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 807018333
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 5


  1. Chronically Acting CFTR Inhibitor Discovery for Secretory Diarrhea and ADPKD

    Amount: $224,700.00

    Project Summary Abstract DiscoveryBioMed, Inc. (DBM) has launched an innovative and automation-friendly drug discovery program to screen a collection of small molecular compounds on a human epithelial ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

    Amount: $1,135,118.00

    DESCRIPTION (provided by applicant): An important discovery and validation event occurred recently within human cell-based drug discovery programs at DiscoveryBioMed, Inc. (DBM), yielding a lead clas ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. Inhibitors of IgH Gene Enhancers for the Treatment of Multiple Myeloma

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) has launched an innovative and automation-friendly drug discovery program to screen synthetic organic small molecule collections on dif ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

    Amount: $436,560.00

    DESCRIPTION (provided by applicant): An important discovery and validation event occurred recently within human cell-based drug discovery programs at DiscoveryBioMed, Inc. (DBM), yielding a lead clas ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. Human Adipocyte Platform for Discovery of Novel Adiponectin Secretagogues

    Amount: $221,853.00

    DESCRIPTION (provided by applicant): Small business concerns, DiscoveryBioMed, Inc. (DBM) and Chromadex, Inc. (CDex), have designed an innovative automation-friendly drug discovery program to screen m ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. CF Corrector Ligands Discovered on CF Human Airway Cells

    Amount: $1,379,561.00

    DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) achieved Phase 1 SBIR milestones and seeks to continue a mature program that has progressed to the hit-to-lead drug validation, priorit ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells

    Amount: $234,330.00

    DESCRIPTION (provided by applicant): Project Summary Description Title: Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells. Osteoporosis is a growing problem in the aged and an unfortu ...

    SBIR Phase I 2010 Department of Health and Human Services
  8. Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis

    Amount: $746,326.00

    DESCRIPTION (provided by applicant): Hypertension is a confounding multifactorial disorder that affects millions of patients worldwide. Cystic fibrosis (CF) is an inherited disease of the pulmonary an ...

    SBIR Phase II 2009 Department of Health and Human Services
  9. Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells

    Amount: $322,000.00

    DESCRIPTION (provided by applicant): In this proposed Phase I SBIR program, DiscoveryBioMed, Inc. (DBM) will continue to build upon an active project performed in collaboration with CFTR cell biologis ...

    SBIR Phase I 2009 Department of Health and Human Services
  10. Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis Scientific Summary Description Hypertension is a confounding multifactorial disorder that affects ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government